Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Transient receptor potential cation channel subfamily V member 1 | ||
Ligand | BDBM50046297 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1447592 (CHEMBL3373787) | ||
Ki | 0.400000±n/a nM | ||
Citation | Ryu, H; Seo, S; Cho, SH; Kim, HS; Jung, A; Kang, DW; Son, K; Cui, M; Hong, SH; Sharma, PK; Choi, S; Blumberg, PM; Frank-Foltyn, R; Bahrenberg, G; Stockhausen, H; Schiene, K; Christoph, T; Frormann, S; Lee, J 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists. Bioorg Med Chem Lett24:4039-43 (2014) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Transient receptor potential cation channel subfamily V member 1 | |||
Name: | Transient receptor potential cation channel subfamily V member 1 | ||
Synonyms: | Capsaicin receptor | OTRPC1 | Osm-9-like TRP channel 1 | TRPV1 | TRPV1_HUMAN | Transient receptor potential cation channel subfamily V member 1 | Transient receptor potential cation channel subfamily V member 1 (TRPV1) | Transient receptor potential cation channel subfamily V member 1 (VR1/TRPV1) | Transient receptor potential cation channel subfamily V member 1(TRPV1) | VR1 | Vanilloid VR1 | Vanilloid receptor | Vanilloid receptor 1 | Vanilloid receptor 1 (TrpV1/Vr1) | Vanilloid receptor 1 (VRI/TRPV1) | ||
Type: | Protein | ||
Mol. Mass.: | 94960.75 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q8NER1 | ||
Residue: | 839 | ||
Sequence: |
| ||
BDBM50046297 | |||
n/a | |||
Name | BDBM50046297 | ||
Synonyms: | CHEMBL3314391 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H29F4N3O3S | ||
Mol. Mass. | 515.564 | ||
SMILES | CC(C(=O)NCc1ccc(nc1C1CCC(C)CC1)C(F)(F)F)c1ccc(NS(C)(=O)=O)c(F)c1 |(15.59,-5.14,;15.59,-6.68,;14.26,-7.45,;14.26,-8.99,;12.92,-6.68,;11.59,-7.45,;10.26,-6.68,;10.25,-5.13,;8.92,-4.37,;7.59,-5.14,;7.59,-6.69,;8.92,-7.46,;8.92,-9,;7.58,-9.77,;7.58,-11.3,;8.91,-12.08,;8.9,-13.63,;10.24,-11.31,;10.25,-9.76,;6.25,-4.37,;6.25,-2.83,;4.92,-5.14,;4.92,-3.6,;16.93,-7.44,;16.92,-8.98,;18.25,-9.75,;19.59,-8.98,;20.92,-9.75,;22.26,-8.97,;23.59,-9.74,;23.02,-7.64,;21.48,-7.64,;19.58,-7.43,;20.91,-6.66,;18.25,-6.67,)| | ||
Structure |